1. 2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer. (20th October 2022) Authors: Loverix, Liselore; Salihi, Rawand; van Rompuy, Anne-Sophie; Vanderstichele, Adriaan; van Nieuwenhuysen, Els; Baert, Thaïs; Debruyne, Philip; Cornez, Nathalie; Henry, Stéphanie; Neven, Patrick; Han, Sileny; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Busschaert, Pieter; van Gorp, Toon; Vergote... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-1473-ESGO Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in recurrent ovarian cancer – results of the Leuven HRD test. (20th October 2022) Authors: Loverix, Liselore; Vergote, Ignace; Vanderstichele, Adriaan; Busschaert, Pieter; Boeckx, Bram; Venken, Tom; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Olbrecht, Siel; Laga, Tina; Lambrechts, Diether; van Gorp, Toon Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer. (20th October 2022) Authors: Dumont, Sander; Vandecaveye, Vincent; Dresen, Raphaëla Carmen; van Nieuwenhuysen, Els; Baert, Thaïs; Han, Sileny; Neven, Patrick; Berteloot, Patrick; Amant, Frédéric; van Gorp, Toon Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial. (4th December 2020) Authors: Mäenpää, Johanna; Pothuri, Bhavana; Han, Sileny; Chase, Dana; Bender, David; Follana, Philippe; Bacque, Emeline; Yong, LI; González-Martin, Antonio; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 571 Niraparib in patients with newly diagnosed advanced ovarian brcam cancer: a post hoc analysis of the prima/engot-ov26/gog-3012 trial. (14th December 2020) Authors: Korach, Jacob; Graybill, Whitney; Redondo, Andrés; O'malley, David M; Han, Sileny; Cloven, Noelle; Knudsen, Anja Ør; Lechpammer, Stanislav; González-Martín, Antonio; Monk, Bradley J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines. (20th June 2020) Authors: Dullens, Boudewijn; de Putter, Robin; Lambertini, Matteo; Toss, Angela; Han, Sileny; Van Nieuwenhuysen, Els; Van Gorp, Toon; Vanderstichele, Adriaan; Van Ongeval, Chantal; Keupers, Machteld; Prevos, Renate; Celis, Valerie; Dekervel, Jeroen; Everaerts, Wouter; Wildiers, Hans; Nevelsteen, Ines; Nev... Other Names: Kleeff Jorg Academic Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer. Issue 4 (26th January 2021) Authors: Volcke, Alexander; Van Nieuwenhuysen, Els; Han, Sileny; Salihi, Rawand; Van Gorp, Toon; Vergote, Ignace Journal: Journal of surgical oncology Issue: Volume 123:Issue 4(2021) Page Start: 1109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking. (December 2014) Authors: Vandenbroucke, Tineke; Verheecke, Magali; Van Calsteren, Kristel; Han, Sileny; Claes, Laurence; Amant, Frédéric Journal: Expert opinion on drug safety Issue: Volume 13:Number 12(2014) Page Start: 1653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Importance of pathological review of gestational trophoblastic diseases: results of the Belgian Gestational Trophoblastic Diseases Registry. Issue 6 (29th April 2022) Authors: Schoenen, Sophie; Delbecque, Katty; Van Rompuy, Anne-Sophie; Marbaix, Etienne; Noel, Jean-Christophe; Delvenne, Philippe; Moerman, Philippe; Vergote, Ignace; Kridelka, Frédéric; Vandewal, Aleide; Han, Sileny; Goffin, Frederic Journal: International journal of gynecological cancer Issue: Volume 32:Issue 6(2022) Page Start: 740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy. Issue 4 (19th February 2020) Authors: Loverix, Liselore; Salihi, Rawand Rokan; Van Nieuwenhuysen, Els; Concin, Nicole; Han, Sileny; van Gorp, Toon; Vergote, Ignace Journal: International journal of gynecological cancer Issue: Volume 30:Issue 4(2020) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗